Psoriatic arthritis trials in Netherlands

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

  Where

  Amsterdam, Rotterdam, Utrecht

  Age

  5 years to 17 years

  People

  60 worldwide

  Run by

  Amgen

  See details and how to joinNCT04804553 · EU 2023-503435-17-00
• Phase 4Taking people
  REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

  Where

  Amsterdam, Enschede, Harderwijk, Maastricht, Nijmegen, Rotterdam, Tilburg, Ubbergen, Uden, Zwolle

  Age

  16 years and over

  People

  200

  Run by

  Sint Maartenskliniek

  See details and how to joinNCT07160231 · EU 2025-520757-36-00
• Phase 4Taking people
  Comparing the effectiveness of tofacitinib extended release (XR) chronotherapy, morning versus evening dosing, in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients from a patient's, clinical as well as a translational point of view.

  Where

  Capelle aan den IJssel, Rotterdam

  Age

  18 years and over

  People

  84

  Run by

  Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

  See details and how to join2024-517865-17-01 · EU 2024-517865-17-01